Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:March 4, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:March 4, 2024Not yet recruiting
Condition(s):Wild-type RAS Metastatic Colorectal CancerLast Updated:November 8, 2022Completed
Condition(s):Colorectal CancerLast Updated:July 31, 2019Completed
Condition(s):Advanced or Recurrent Colorectal CancerLast Updated:April 6, 2017Completed
Condition(s):Pancreatic CancerLast Updated:March 20, 2017Completed
Condition(s):Carcinoma, Squamous CellLast Updated:August 30, 2010Unknown status
Condition(s):Colorectal CancerLast Updated:May 16, 2017Completed
Condition(s):Head and Neck CancerLast Updated:December 22, 2023Recruiting
Condition(s):Head and Neck CancerLast Updated:April 16, 2019Completed
Condition(s):Metastatic Colon CancerLast Updated:October 7, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.